The objective of GrüneLabs is the production of special medicines that can treat neurological diseases and other pathologies.

WHO WE ARE

GrüneLabs is a pharmaceutical laboratory located in Uruguay which seeks innovation in the processing of botanical specialties for the production of medicines with high technology, for children, adult and veterinary uses.

GMP CERTIFICATION

GrüneLabs aims to produce standardized active pharmaceutical ingredients (API), inputs used by the pharmaceutical industry for the development and production of drugs.

Each stage of the manufacturing process will be certified by GMP (good manufacturing practices).

The GMP certification is a requirement of the pharmaceutical industry that guarantees the consistency in the active ingredients that can affect the safety and effectiveness of a medicine.

As the world’s second largest producer of GMP certified medicinal cannabis in standardized flower, GrüneLabs will be authorized to export plant material and extracts for the global pharmaceutical industry.

CONTACT US

2 + 3 =

Open talk about the Endocannabinoid System

Last Thursday, April 5, in the University of Chemistry of Uruguay, a free and open talk about the functioning of the endocannabinoid system was held. On that occasion, Ph.D in Neuroscience Renato Malcher explained in a simple way how cannabis works in the brain and...

A talk with Raphael Mechoulam

One of the experts working in cooperation with Grüne Labs, Ph.D in Neuroscience Renato Malcher, had the opportunity to attend the new edition of CannaTech, an event that brings together leaders from the global industry, covering the fields of science, research,...

Medical Cannabis

The most common use for medical cannabis in the United States is for pain control. While cannabis isn’t strong enough for severe pain (for example, post-surgical pain or a broken bone), it is quite effective for the chronic pain that plagues millions of Americans,...